tm logo
Trademark Search
EMTOVYS XR

View On IC.GC.CA

EMTOVYS XR
ABANDONED SECTION 36

on 21 Sep 2020

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001

US

Serial Number

1816802 filed on 05th Jan 2017

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

EMTOVYS XR

Trademark usage description

human pharmaceutical preparations for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncolo Read More

Classification Information

Class [005]
Human pharmaceutical preparations for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; human pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; human pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; human pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; human pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; human pharmaceuticals preparations, namely anti-virals, anti-inflammatories, anti-infectives and vaccines; human pharmaceutical preparations for the relief of pain

Classification kind code

11

Mark Details

Serial Number

1816802

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 25th May 2018		Allowed
Submitted for opposition 51
on 25th May 2018		Allowance Notice Sent
Submitted for opposition 42
on 07th Feb 2018		Advertised
Submitted for opposition 26
on 18th Jan 2018		Approved
Submitted for opposition 27
on 28th Nov 2017		Approval Notice Sent
Submitted for opposition 22
on 13th Oct 2017		Search Recorded
Submitted for opposition 20
on 13th Oct 2017		Examiner's First Report
Submitted for opposition 31
on 10th Jan 2017		Formalized
Submitted for opposition 1
on 06th Jan 2017		Created
Submitted for opposition 30
on 05th Jan 2017		Filed